This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Andrew F. Kelliher, MS, RPh; George Alexis, MS, RPh
Brockton, Mass

Arch Intern Med. 1995;155(9):990.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Hirsch and Poller's¹ article in the February 14, 1994, issue of the ARCHIVES contains a protocol of subcutaneous phytonadione to reverse warfarin overanticoagulation. They referenced an article that appeared in Chest in 1992.² The article contained an intravenous phytonadione protocol. We would like to know the rationale for the change in the route of administration. Are both routes equally effective? . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?